GSK plc vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
GSK
High-quality business with 41% return on equity and 18% profit margins.
⚠ cautious analyst consensus — few Buy ratings.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $57.65 (+11.7%)
8 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
GSK
JNJ
13.4×
Trailing P/E
26.3×
9.9×
Forward P/E
17.9×
17.8%
Profit Margin
21.8%
72.9%
Gross Margin
68.0%
40.9%
ROE
26.4%
1.5%
Revenue Growth
9.9%
8.4%
Earnings Growth
-52.9%
0.35
Beta
0.33
—
Price / Book
—
$103.0B
Market Cap
$546.9B
$35 – $62
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →